PRESS RELEASE published on 03/05/2024 at 08:00, 2 years ago Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials BRAIN Biotech AG and AMSilk collaborate on protein engineering for performance materials, registering their first patent application. The strategic partnership aims for sustainable bio-based solutions in the textile industry Sustainability BRAIN Biotech AG AMSilk Protein Engineering Performance Materials
BRIEF published on 02/29/2024 at 20:45, 2 years ago BRAIN Biotech AG Announces EUR 5.0 Million Convertible Bond Placement for Growth Initiatives Non-dilutive Financing Convertible Bond Corporate Strategy BRAIN Biotech AG Financing Growth
BRIEF published on 02/29/2024 at 20:45, 2 years ago BRAIN Biotech AG annonce un placement d'obligations convertibles de 5,0 millions d'euros pour des initiatives de croissance Stratégie D'entreprise Obligations Convertibles BRAIN Biotech SA Financer La Croissance Financement Non Dilutif
PRESS RELEASE published on 02/29/2024 at 20:40, 2 years ago BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for financing of growth initiatives. The bonds have an interest rate of 6.52% p.a. and a maturity date of 5 September 2026 Financing Convertible Bond BRAIN Biotech AG Growth Initiatives EUR 5.0 Million
BRIEF published on 02/29/2024 at 20:11, 2 years ago BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
BRIEF published on 02/29/2024 at 20:11, 2 years ago BRAIN Biotech AG annonce l'émission d'une obligation convertible de 5 millions d'euros Stratégie Financière BRAIN Biotech SA Liens Convertibles Financement D'entreprise Droits Des Actionnaires
PRESS RELEASE published on 02/29/2024 at 20:06, 2 years ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
BRIEF published on 02/28/2024 at 07:30, 2 years ago BRAIN Biotech AG : Bilan du premier trimestre de l'exercice 2023/24 Croissance Organique Rapport Financier BRAIN Biotech AG BioScience BioProduits
BRIEF published on 02/28/2024 at 07:30, 2 years ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 02/28/2024 at 07:30, 2 years ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
Published on 03/20/2026 at 13:30, 1 day 16 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 17 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 1 day 7 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 9 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 9 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 9 hours ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 10 hours ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 1 day 11 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 11 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 11 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 11 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA